Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Due to In-Host Microevolution. 2021

Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
Department of Infectious Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Klebsiella pneumoniae can cause both hospital- and community-acquired clinical infections. Last-line antibiotics against carbapenem-resistant K. pneumoniae (CRKP), such as ceftazidime/avibactam (CZA) and tigecycline (TGC), remain limited as treatment choices. This study aimed to investigate the mechanisms by which CRKP acquires CZA and TGC resistance in vivo under β-lactam antibiotic and TGC exposure. Three CRKP strains (XDX16, XDX31 and XDX51) were consecutively isolated from an inpatient with a urinary tract infection in two months. PFGE and MLST showed that these strains were closely related and belonged to sequence type (ST) 4496, which is a novel ST closely related to ST11. Compared to XDX16 and XDX31, XDX51 developed CZA and TGC resistance. Sequencing showed that double copies of blaKPC-2 were located on a 108 kb IncFII plasmid, increasing blaKPC-2 expression in XDX51. In addition, ramR was interrupted by Insertion sequence (IS) Kpn14 in XDX51, with this strain exhibiting upregulation of ramA, acrA and acrB expression compared with XDX16 and XDX31. Furthermore, LPS analysis suggested that the O-antigen in XDX51 was defective due to ISKpn26 insertion in the rhamnosyl transferase gene wbbL, which slightly reduced TGC susceptibility. In brief, CZA resistance was caused mainly by blaKPC-2 duplication, and TGC resistance was caused by ramR inactivation with additional LPS changes due to IS element insertion in wbbL. Notably, CRKP developed TGC and CZA resistance within one month under TGC and β-lactam treatment without exposure to CZA. The CRKP clone ST4496 has the ability to evolve CZA and TGC resistance rapidly, posing a potential threat to inpatients during antibiotic treatment.

UI MeSH Term Description Entries
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078304 Tigecycline A tetracycline derivative that acts as a protein synthesis inhibitor. It is used as an antibacterial agent for the systemic treatment of complicated skin and intra-abdominal infections. It is also used for the treatment of community-acquired pneumonia. 9-(tert-Butylglycylamido)minocycline,GAR 936,GAR-936,TBG-MINO,Tygacil,GAR936
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D015780 Carbapenems A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain. Antibiotics, Carbapenem,Carbapenem,Carbapenem Antibiotics
D053961 Azabicyclo Compounds Bicyclic bridged compounds that contain a nitrogen which has three bonds. The nomenclature indicates the number of atoms in each path around the rings, such as [2.2.2] for three equal length paths. Some members are TROPANES and BETA LACTAMS. Azabicyclo(1.1.0)Butanes,Azabicyclo(2.2.2)Octanes,Azabicyclo(3.3.1)Nonanes,Azabicyclo(4.3.0)Nonanes,Azabicyclo(5.2.2)Undecanes

Related Publications

Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
January 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
May 2022, Journal of infection and public health,
Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
March 2017, Antimicrobial agents and chemotherapy,
Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
January 2022, Infection and drug resistance,
Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
June 2022, Journal of global antimicrobial resistance,
Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
January 2022, Enfermedades infecciosas y microbiologia clinica (English ed.),
Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
April 2021, Enfermedades infecciosas y microbiologia clinica (English ed.),
Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
January 2021, Frontiers in microbiology,
Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
May 2022, Antibiotics (Basel, Switzerland),
Xinhong Han, and Qiucheng Shi, and Yihan Mao, and Jingjing Quan, and Ping Zhang, and Peng Lan, and Yan Jiang, and Dongdong Zhao, and Xueqing Wu, and Xiaoting Hua, and Yunsong Yu
May 2024, Indian journal of medical microbiology,
Copied contents to your clipboard!